共 50 条
- [31] RATIONAL BASES FOR ADRIAMYCIN (NSC-123127) COMBINATION THERAPY [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 227 - 230
- [32] DNA COMPLEXES OF DAUNORUBICIN (NSC-82151) AND ADRIAMYCIN (NSC-123127) [J]. CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (02): : 260 - 260
- [33] ADRIAMYCIN (NSC-123127) THERAPY IN THYROID-CARCINOMA [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 283 - 296
- [34] DEVELOPMENT OF RESISTANCE TO ADRIAMYCIN (NSC-123127) IN EHRLICH ASCITES TUMOR IN-VIVO [J]. CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (03): : 321 - +
- [35] COMBINATION USAGE OF ADRIAMYCIN (NSC-123127) IN MALIGNANT LYMPHOMAS [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 381 - 388
- [37] ADRIAMYCIN (NSC-123127) - NEW CHEMICAL DEVELOPMENTS AND ANALOGS [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 123 - 129
- [38] DAUNOMYCIN (NSC-82151) AND ADRIAMYCIN (NSC-123127) - HYPOTHESIS CONCERNING ANTITUMOR ACTIVITY AND CARDIOTOXICITY [J]. CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (03): : 293 - 294
- [39] ADRIAMYCIN (NSC-123127) IN TREATMENT OF ACUTE MYELOCYTIC LEUKEMIA [J]. CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (02): : 237 - +
- [40] ADRIAMYCIN (NSC-123127) TOXICITY - UNUSUAL MELANOTIC REACTION [J]. CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (05): : 749 - 751